Intraductal papillary mucinous neoplasms of the pancreas: indication, extent, and results of surgery.
In intraductal and papillary mucinous neoplasm (IPMN) of the pancreas, the aims of surgery differ according to the presence of malignancy. For malignant IPMN and especially for invasive malignancy, radical resection is essential, but entails a substantial operative risk and long-term pancreatic insufficiency. For benign IPMN, in theory, the operative risk and the loss of pancreatic function should be minimal. Thus, surgery for malignant and benign IPMN differs in patient selection, surgical technique, and accepted risk of long-term functional disorders. This article details the indications, surgical techniques, and results of surgery in IPMN.
Sauvanet
Alain
A
Service de Chirurgie Digestive, Hôpital Beaujon, Université Paris VII, AP-HP, 100 Bd du Général Leclerc, 92118 Clichy-Cedex, France. alain.sauvanet@bjn.ap-hop-paris.fr
D002288:Adenocarcinoma, Mucinous / Q000175:diagnosis / Q000503:physiopathology / Q000601:surgery*; D021441:Carcinoma, Pancreatic Ductal / Q000175:diagnosis / Q000503:physiopathology / Q000601:surgery*; D006801:Humans; D010190:Pancreatic Neoplasms / Q000175:diagnosis / Q000503:physiopathology / Q000601:surgery*; D011300:Preoperative Care; D016896:Treatment Outcome